The license enables Bionova to integrate the Clean Genome strain into its pDNA production workflows to support client programs.

Dr. Stacy Lindborg is president and CEO of IMUNON, a clinical-stage company in phase 3 development with a lead DNA-mediated immunotherapy for advanced ovarian cancer. Dr. Lindborg has worked in the ...

OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall ...

Global mRNA Synthesis and Manufacturing Market OverviewThe global mRNA synthesis and manufacturing market is projected to grow at a compound annual growth rate of approximately 6% during the forecast ...

Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing ...

Greetings, and welcome to Azenta Q1 2020 Financial Results. [Operator Instructions] As a reminder, this conference is being recorded, Wednesday, February 4, 2026. I will now turn the conference over ...

The Seattle facility of AGC Biologics, your friendly CDMO expert, has received a Good Manufacturing Practices Certification from Agência Nacional de Vigilância Sanitária (Anvisa), Brazil's health ...

Upregulated expression of transcription factors promoting cone identity in late-stage retinal progenitors drives development ...

A bacterial biosensor created by researchers from The Hebrew University of Jerusalem (Rehovot, Israel) lights up in the ...

From penetrating solid tumors to new success rates for de novo design, the next wave of antibody therapies aims to transform the clinic.

Aircraft wing-shaped structures inside tiny channels produce consistent drug delivery particles at any scale, from small laboratory tests to factory production, while substantially cutting costs.

Get all latest & breaking news on Zydus Cadila. Watch videos, top stories and articles on Zydus Cadila at moneycontrol.com.